Sage Group PLC (SGE)
London Exchange · UK · prices in GBX · close of 19 Oct 2026
Key indicators
| Last close | GBX 1,139.50 |
|---|---|
| 52-week range | 764.38 – 1,154.29 |
| Return, 1 month / 3 months | +13.0% / +36.4% |
| Return, 1 year / 3 years | +2.4% / +26.7% |
| Trend | Uptrend |
| RSI (14) | 71 |
| Volatility (1 year) | 34.2% |
| Worst drawdown (1 year) | -32.4% |
| Average daily value traded | 3,213.77M GBX |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sage Group is a British software company that provides accounting, payroll, invoicing and business management software, mainly to small and medium-sized businesses. Its products help owners and finance teams keep books, pay staff, manage cash flow and handle tax and compliance tasks, and it also offers cloud-based tools that connect these functions online. The company is based in Newcastle upon Tyne in the United Kingdom and serves customers in many countries through its own teams and partner networks.
Sage Group PLC trades under the code SGE on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sage Group PLC (SGE) trades on the London Exchange in UK. It last closed at GBX 1,139.50 on 19 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 583 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 2.4% and over the last three months it rose 36.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 90 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 24.4% | ||
| From 52-week high | -0.8% | ||
| Momentum | 70 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 36.4% | ||
| 6-month return | 25.5% | ||
| 12-month return, skipping the last month | -9.3% | ||
| Stability (higher is calmer) | 48 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 34.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.4% | ||
| Liquidity | 99 · Strong | Trades actively. | |
| Average daily value traded | 3,213.77M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 24 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +5.1% |
|---|---|
| 1 month | +13.0% |
| 3 months | +36.4% |
| 6 months | +25.5% |
| 1 year | +2.4% |
| 3 years | +26.7% |
| 5 years | +77.6% |
Signals
| 50-day / 200-day average | 1,039.05 / 916.18 |
|---|---|
| Golden / death cross (60 days) | Golden, 37 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 31.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Jun 2026 | GBP 0.0805 |
| 8 Jan 2026 | GBP 0.1440 |
| 29 May 2025 | GBP 0.0745 |
| 9 Jan 2025 | GBP 0.1350 |
| 30 May 2024 | GBP 0.0695 |
| 11 Jan 2024 | GBP 0.1275 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.